Diabetic kidney disease (DKD) is not only one of the main complications of diabetes, but also the leading cause of the end-stage renal disease (ESRD). The occurrence and development of DKD have always been a serious clinical problem that leads to the increase of morbidity and mortality and ...
thus untethering them from tri-weekly visits to dialysis centers. It also could be used in an interim device in developing an implantable bio-artificial kidney, in which cell therapy would augment the function of the downstream filter to replace most of the functions...
"African Americans develop end stagekidney diseaseat four times the rate of white Americans and represent more than 30% of people on dialysis," said lead author Opeyemi Olabisi, M.D., Ph.D., associate professor in the Department of Medicine at Duke University School of Medicine. "For more ...
New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant. Kidney Int 2016; 89: 988-994 [PMID: 27083277 DOI: 10.1016/j.kint.2016.01.011]PABRIZI F, MARTIN P, MESSA P. New treatment for hepati- tis C in chronic kidney disease, dialysis, and trans- plant [J]. ...
Kidney damage and exfoliative dermatitis occur less commonly. Suramin has been applied clinically to HIV/AIDS patients resulting in a significant number of fatal occurrences and as a result the application of this molecule was abandoned for this condition. http://www.ncbi.nlm.nih.gov/pubmed/354835...
New Kidney Unit Will Change Lives; DIALYSIS PATIENT LOOKS FORWARD TO A LESS STRESSFUL ROUTINE 来自 questia.com 喜欢 0 阅读量: 43 作者: CE Telegraph 摘要: Read the full-text online article and more details about "New Kidney Unit Will Change Lives; DIALYSIS PATIENT LOOKS FORWARD TO A LESS ...
New York, Aug 30:In a breakthrough, US scientists have, for the first time, developed an implantable device that could one day free kidney failure patients from needing dialysis or having to take harsh drugs to suppress their immune system after a transplant. ...
this material?” If enough immune cells recognise the tissue, those that don’t are screened out and killed. Because donated immune cells recognise the foreign tissue from the transplanted kidney, the thymus gets rid of the recipient’s own T-cells that could otherwise attack the kidney. ...
from our group using G-CSF (12 doses 5 μg/kg s.c. each over 1 mo) in patients with ACLF (57% had alcoholic hepatitis) has shown mobilization of CD34+ stem cells, with significantly improved survival, and decreased the risk of bacterial infection and kidney failure in G-CSF group[95...
The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform for in-depth discussions and exchange on recen